ArticleCell death discovery2025

RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting.

Zengbin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.